top of page

Browse by category

Search

First commercial patient treated with Morphic Medical’s RESET device

First commercial patient treated with Morphic Medical’s RESET device

First commercial patient treated with Morphic Medical’s RESET device

Morphic Medical has announced that the first commercial patient has been treated with RESET, the company’s therapy designed to target the...

Morphic Medical gains CE Mark for RESET endoscopic device

Morphic Medical gains CE Mark for RESET endoscopic device

Morphic Medical gains CE Mark for RESET endoscopic device

Morphic Medical has received CE (Conformité Européenne) Mark approval for the RESET System, which according to the company is designed to...

GI Dynamics rebrands as Morphic Medical and reintroduces RESET, formerly the EndoBarrier

GI Dynamics rebrands as Morphic Medical and reintroduces RESET, formerly the EndoBarrier

GI Dynamics rebrands as Morphic Medical and reintroduces RESET, formerly the EndoBarrier

GI Dynamics, the creator of the EndoBarrier device designed to target the underlying cause of type 2 diabetes, has announced it has...

Download Bariatric News issue 56

6 days ago

Ascletis completes enrolment in US study for once-monthly subcutaneous depot treatment GLP-1R agonist ASC30 for obesity

Oct 20

FDA approves Novo Nordisk’s oral semaglutide (Rybelsus) for CV risk reduction in T2DM adults

Oct 20

Back to Top

bottom of page